pembrolizumab,atezolizumab,durvalumab,cisplatin,gemcitabine,bevacizumab
roche,merck,astrazeneca
['imbrave050', 'hcc', 'atezo', 'topaz1', 'gi ', 'kn966']
catching up on #aacr23 gi updates imbrave050 adjuv atezo+bev h-risk hcc delay in recurrence os benefit not clear which 1st line after dp?
kn966 1st line pem+cis+gem btc must be seen in context w/ topaz1 pfs statistics neg feasible option vs interchangeble? 
Medical Oncologist at Hospital Sírio-Libanês GI cancers & TO research 🧬 🇧🇷 @SBOC_Oncologia Jovens Oncologistas @ASCO Trainee & Early Career Advisory Group